In accordance with this, the combined use of INI and ICP, taken in a certain ratio that is optimal for the effective formation of heterooligomeric complexes, can become a promising approach for correcting the deficiency of the insulin signaling (and, possibly, the C-peptide signaling) in the brain in T1DM. This evidence concerns the gene INS and type 1 diabetes mellitus.